REGISTERED NUMBER: 13195061 (England and Wales)

Unaudited Financial Statements

for the Year Ended

28 February 2026

for

Axe Ventures Limited

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

DIRECTOR:

E J Axelrad

REGISTERED OFFICE:

Bank Farm

Carlton

Nuneaton

Warwickshire

CV13 0BU

REGISTERED NUMBER:

13195061 (England and Wales)

FIXED ASSETS

Investments

4

1,700,166

1,700,166

CURRENT ASSETS

Debtors

5

5,590,000

4,000,000

Cash at bank

2,873

321

5,592,873

4,000,321

CREDITORS

Amounts falling due within one year

6

7,399,738

5,808,571

NET CURRENT LIABILITIES

(1,806,865

)

(1,808,250

)

TOTAL ASSETS LESS CURRENT LIABILITIES

(106,699

)

(108,084

)

CAPITAL AND RESERVES

Called up share capital

7

100

100

Retained earnings

(106,799

)

(108,184

)

SHAREHOLDERS' FUNDS

(106,699

)

(108,084

)

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 28 February 2026.

The members have not required the company to obtain an audit of its financial statements for the year ended 28 February 2026 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 28 May 2026 and were signed by:

E J Axelrad - Director

1.	STATUTORY INFORMATION

Axe Ventures Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Investments in subsidiaries

Investments in subsidiary undertakings are recognised at cost less any provision for impairment.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2025 - NIL).

4.	FIXED ASSET INVESTMENTS

Shares in

group

undertakings

£

COST

At 1 March 2025

and 28 February 2026

1,700,166

NET BOOK VALUE

At 28 February 2026

1,700,166

At 28 February 2025

1,700,166

5.

DEBTORS

28.2.26

28.2.25

£

£

Amounts falling due within one year:

Amounts owed by group undertakings

5,590,000

-

Amounts falling due after more than one year:

Amounts owed by group undertakings

-

4,000,000

Aggregate amounts

5,590,000

4,000,000

6.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

28.2.26

28.2.25

£

£

Directors' current account

7,398,700

5,807,700

Accruals and deferred income

1,038

871

7,399,738

5,808,571

7.	CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:

Number:

Class:

Nominal

28.2.26

28.2.25

value:

£

£

50

Ordinary A

£1

50

50

50

Ordinary B

£1

50

50

100

100

8.	RELATED PARTY DISCLOSURES

At the period end, included in debtors is a long term loan of £5,590,000 (2025 - £4,000,000) to Medicus Health Ltd, a company which Axe Venture Ltd has a controlling interest. From 1 January 2024 interest is payable on the loan at 1% above base rate.

9.	GOING CONCERN

The company relies on the continuing support of its director. The director has agreed to continue to support the company for the foreseeable future as necessary.

10.	POST BALANCE SHEET EVENT

After the year end Axe Venture Ltd sold its shares in Medicus Health Ltd on the 1 May 2026, as part of the sale £5,590,000 of outstanding debt owed by Medicus Health Ltd was repaid in full.